Outlook Therapeutics, Inc

Celgene Corp, based in Warren, NJ, is a global biopharmaceutical company that focuses on developing innovative medicines to improve the lives of patients worldwide. With a strong presence in various markets across the Americas, Asia Pacific, Europe, and the Middle East, Celgene is dedicated to advancing research in areas such as immunology, oncology, and stem cell therapy. Through strategic partnerships, ongoing clinical trials, and a commitment to global inclusion and diversity, Celgene continues to drive progress in the field of biopharmaceuticals. The company's dedication to improving patient outcomes and shaping the future of healthcare is evident in its diverse portfolio of medicines and collaborative efforts with healthcare providers and researchers. Generated from the website

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to other products and services.

Insmed Incorporated is a biopharmaceutical company focused on development and commercialization of drug formulations for treatment of metabolic diseases and endocrine disorders. The company, located in Glen Allen, Va., focuses on correcting metabolic defects in human body by replacing key proteins physiologically. It develops drugs that modulate insulin-like growth factor-1 activity in human body. Insmed Incorporated offers various drug candidates, such as recombinant human IGF-1 bound to protein-3, and IPLEX, which is mecasermin rinfabate injection for treatment of growth failure in children with severe IGF-I deficiency. The company also offers anti-cancer drugs, such as recombinant human insulin-like growth factor binding protein-3, and INSM-18. It develops drugs to treat indications in metabolic and oncology fields.